Verition Fund Management LLC Buys Shares of 3,484 National Health Investors, Inc. (NYSE:NHI)

Verition Fund Management LLC purchased a new position in shares of National Health Investors, Inc. (NYSE:NHI) in the 3rd quarter, Holdings Channel reports. The institutional investor purchased 3,484 shares of the real estate investment trust’s stock, valued at approximately $293,000.

Several other institutional investors and hedge funds have also made changes to their positions in NHI. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in National Health Investors by 332.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 242,326 shares of the real estate investment trust’s stock worth $20,370,000 after acquiring an additional 186,238 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in National Health Investors by 17.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust’s stock valued at $71,651,000 after buying an additional 123,596 shares in the last quarter. Waterfront Capital Partners LLC acquired a new stake in National Health Investors during the 3rd quarter valued at $10,097,000. Lee Danner & Bass Inc. purchased a new position in National Health Investors during the second quarter worth $5,089,000. Finally, Easterly Investment Partners LLC acquired a new position in shares of National Health Investors in the third quarter worth $5,632,000. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

National Health Investors Stock Performance

Shares of NHI stock opened at $72.76 on Friday. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. The firm has a market capitalization of $3.30 billion, a price-to-earnings ratio of 25.00, a price-to-earnings-growth ratio of 4.87 and a beta of 1.04. National Health Investors, Inc. has a one year low of $51.59 and a one year high of $86.13. The company has a 50 day moving average price of $77.01 and a 200 day moving average price of $75.45.

National Health Investors (NYSE:NHI) last issued its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm had revenue of $63.32 million during the quarter, compared to analysts’ expectations of $67.93 million. During the same period last year, the business posted $1.08 earnings per share. The company’s quarterly revenue was up 1.7% compared to the same quarter last year. Sell-side analysts anticipate that National Health Investors, Inc. will post 4.42 EPS for the current year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.95%. The ex-dividend date is Tuesday, December 31st. National Health Investors’s payout ratio is currently 123.71%.

Analysts Set New Price Targets

NHI has been the subject of a number of recent research reports. Truist Financial lifted their price objective on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. StockNews.com downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Bank of America started coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price on the stock. Finally, Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their price target for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $76.33.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.